Donald L. Gilbert, MD, MS

AACAP Annual Meeting 2026

October 26–31, 2026 · Atlanta, GA · Full program

• PosterThe Safety and Effect of Ecopipam During the First 8 Weeks of Tourette’s Disorder Treatment: A Post-Hoc Analysis

  October 28, 2026, 13:00–15:00

  Post-hoc analysis of the safety and effects of ecopipam over the first 8 weeks of treatment in Tourette's disorder.

  Autism & Neurodevelopmental DisordersChild & AdolescentDrug Pipeline & Clinical Trials

• PosterLong-Term Safety and Effect of Ecopipam, a Selective Dopamine D1 Receptor Antagonist, in Children, Adolescents, and Adults With Tourette's Disorder

  October 28, 2026, 13:00–15:00

  Reports long-term safety and efficacy of the D1 antagonist ecopipam in Tourette's disorder across children, adolescents and adults.

  Autism & Neurodevelopmental DisordersChild & AdolescentDrug Pipeline & Clinical Trials

• LectureAccelerated Theta Burst Stimulation for Treatment-Resistant Depression in ASD: Clinical, Cognitive, and EEG Outcomes From the RESTORE Randomized Controlled Trial

  October 29, 2026, 11:30–13:00

  Randomized trial results on accelerated theta burst stimulation for treatment-resistant depression in autistic patients, covering clinical, cognitive and EEG outcomes.

  Autism & Neurodevelopmental DisordersNeuromodulation (ECT, TMS)Treatment-Resistant Depression

• PosterClinician Knowledge and Implementation Barriers to Adolescent Transcranial Magnetic Stimulation ( TMS) After FDA Approval: A Cross‑Sectional Study

  October 29, 2026, 13:00–15:00

  Cross-sectional survey of clinician knowledge and barriers to implementing TMS for adolescents following FDA approval.

  Child & AdolescentNeuromodulation (ECT, TMS)Practice, Policy & Workforce